Candel Therapeutics, Inc. (CADL) ownership: Top institutional holder: FMR LLC ($53.84M). Insider activity: Net Seller (1 buys, 19 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| FMR LLC | 10987017.00 | $53.84M | 2026-03-31 |
| RTW INVESTMENTS, LP | 6422018.00 | $31.47M | 2026-03-31 |
| ACORN CAPITAL ADVISORS, LLC | 3497948.00 | $17.21M | 2026-03-31 |
| BlackRock, Inc. | 3109042.00 | $15.23M | 2026-03-31 |
| Saturn V Capital Management LP | 2896588.00 | $14.19M | 2026-03-31 |
| Portolan Capital Management, LLC | 2894325.00 | $14.18M | 2026-03-31 |
| VANGUARD GROUP INC | 2305060.00 | $13.02M | 2025-12-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2462757.00 | $12.07M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-03-31 | |
| Sell | null | 2026-03-31 | |
| Sell | null | 2026-03-31 | |
| Buy | null | 2026-02-23 | |
| Sell | null | 2026-01-26 | |
| Sell | null | 2026-01-26 | |
| Sell | null | 2026-01-26 | |
| Sell | null | 2026-01-26 |
Back to CADL overview · CADL earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.